PLOS One, 2025
Identification of plasma proteins associated with seizures in epilepsy: A consensus machine learning approach

Ashtiani S., Akel S., Banote R. et al.

Scientific Reports, 2025
Childhood obesity and insulin resistance is correlated with gut microbiome serum protein: an integrated metagenomic and proteomic analysis

Liu L., Li M., Qin Y. et al.

Critical Care, 2025
Serial proteomic and metabolomic profiling for early neuroprognostication after out-of-hospital cardiac arrest: a prospective observational study

Liu X., Woo K., Chen L. et al.

Vaccine, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adults

Chan C., Ooi J., Koh C. et al.

npj Precision Oncology, 2025
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns

Daher-Ghanem N., Sharon S., Tao D. et al.

Nature Communications, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Hansen J., Israelsen M., Nishijima S. et al.

Scientific Reports, 2025
Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank

Smith A., Elliott P., Mayr M. et al.

Nature Communications, 2025
Air pollution-induced proteomic alterations increase the risk of child respiratory infections

Brustad N., Wang T., He S. et al.

Nature Communications, 2025
Shared genetic architecture of posttraumatic stress disorder with cardiovascular imaging, risk, and diagnoses

Shen J., Valentim W., Friligkou E. et al.

International Journal of Molecular Sciences, 2025
Identification of Potential Therapeutic Targets for Coronary Atherosclerosis from an Inflammatory Perspective Through Integrated Proteomics and Single-Cell Omics

Wang H., Xie F., Wang M. et al.

BMC Neurology, 2025
Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study

Su B., He Z., Shi L. et al.

Journal for ImmunoTherapy of Cancer, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Patel S., Fisher J., Chae Y. et al.

International Journal of Surgery, 2025
Plasma proteomics profiles predict the risk of future aortic aneurysm and aortic dissection

Li M., He X., Gong W. et al.

Gut Microbes, 2025
Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration

Zhang M., Huang X., Zhang Y. et al.

Signal Transduction and Targeted Therapy, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

Toulmonde M., Guégan J., Spalato-Ceruso M. et al.

Depression and Anxiety, 2025
Proteomic Biomarkers as Mediators in the Association Between Air Pollution and Incident Depression and Anxiety: Evidence From the UK Biobank

Wang M., Ma Y., Zheng Y. et al.

Neurological Sciences, 2025
Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis

Chen K., Zeng C., Ren Y. et al.

Kidney International, 2025
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis

Gupta S., Mistry K., Alikhan F. et al.

JACC: Advances, 2025
Hepatocyte Growth Factor

Holt M., Michelsen A., Flø A. et al.

European Journal of Preventive Cardiology, 2025
Evaluation of Large-Scale Plasma Proteomics for Prediction of Heart Failure in Individuals with A Full Range of Glucose Metabolism Profiles

Zhang Y., Hou R., Sun W. et al.